Vaccine News and Research

Latest Vaccine News and Research

CDC recommends additional dose of mRNA COVID-19 vaccine in moderately to severely immunocompromised people

Today, I signed CDC's Advisory Committee on Immunization Practices' (ACIP) recommendation that endorsed the use of an additional dose of COVID-19 vaccine for people with moderately to severely compromised immune systems after an initial two-dose vaccine series.

13 Aug 2021

Pfizer CEO to public: Just trust us on the covid booster

Pfizer CEO Albert Bourla was confident in June about the ability of his company's vaccine to protect against the highly contagious delta variant, as it marched across the globe and filled U.S. hospitals with patients.

13 Aug 2021

How replication and recombination contribute to emergence of SARS-CoV-2 variants

The coronavirus disease 2019 (COVID-19) pandemic has been caused by the rapid outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 was first reported in late December 2019 in Wuhan, China. Since then, the virus has already claimed more than 4.3 million lives worldwide.

13 Aug 2021

Advances in plant-made vaccines revive interest in plant-produced pharmaceuticals and edible drugs

Recent progress in developing and testing plant-made vaccines has revived interest in plant-produced pharmaceuticals, including edible drugs, for human use. Advances in technology and manufacturing could boost the uptake of therapeutics made in this way, say Hugues Fausther-Bovendo and Gary Kobinger in this Perspective.

13 Aug 2021

Research debunks myth that COVID vaccination promotes mutations

A study conducted by researchers at the University of Maryland, USA, has highlighted the importance of coronavirus disease 2019 (COVID-19) vaccination in reducing the frequency of mutations in the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

13 Aug 2021

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

A team of scientists from Frankfurt, Germany, has recently explored the efficacy of vaccine- or infection-induced antibodies and therapeutic monoclonal antibodies in neutralizing kappa and delta variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

12 Aug 2021

CDC's mask guidance may have increased the threat of COVID-19 among vulnerable communities

The Centers for Disease Control and Prevention may have increased the threat of COVID-19 infection in the Black community and among some other racial and ethnic minority groups when the agency updated its mask guidance last May, according to a new commentary in the Journal of General Internal Medicine by two colleagues at Massachusetts General Hospital.

12 Aug 2021

PAHO Director expresses concern about COVID-19 vaccine hesitancy in Caribbean countries

Dr. Carissa F. Etienne, Director of the Pan American Health Organization (PAHO), expressed concern about COVID-19 vaccine hesitancy in Caribbean countries and made a strong appeal to people to get vaccinated.

12 Aug 2021

Over 70% of young people in England vaccinated with a first dose of COVID-19 vaccine

Over 70% of young people aged 18 to 29 in England have received a first dose of a COVID-19 vaccine, the latest figures show, providing vital protection against infection and serious illness from the virus.

12 Aug 2021

KHN’s ‘What the Health?’: The Senate acts

The Senate has set the stage for a busy fall that will include debate on a broad array of health issues, such as prescription drug prices, Medicare expansion and further expansion of the Affordable Care Act.

12 Aug 2021

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

A South Australian-developed SARS-CoV-19 vaccine is preparing to progress to the final stages of human clinical trials after early animal testing confirmed its safety and effectiveness in preventing COVID-19 lung infection.

12 Aug 2021

Reading, ’rithmetic and resisting covid: The new 3 R’s as kids head back to school

When kids head back to school this fall, for some it will be the first time they've been in a real classroom with other students since the pandemic began.

12 Aug 2021

National academies’ report took pharma-friendly stance after millions in gifts from drugmakers

To several U.S. senators, it looked wasteful, even outrageous. Every year, taxpayers pay for at least $750 million worth of expensive pharmaceuticals that are simply thrown away. Companies ship many of the drugs in "Costco"-size vials, one lawmaker said, that once opened usually cannot be resealed or saved for other patients. Yet pharma gets paid for every drop.

12 Aug 2021

Getting a covid vaccine during pregnancy even more urgent as ICU beds fill up

The Centers for Disease Control and Prevention is doubling down on its recommendation that people who are pregnant get the covid-19 vaccine, in light of new data underscoring its safety and effectiveness throughout pregnancy.

12 Aug 2021

Immunogenicity of mRNA vaccine against emerging strains of SARS-CoV-2 in immunocompromised patients

A study measured neutralization of SARS-CoV-2 and vaccine responses in immunocompromised patients with systemic inflammatory diseases.

11 Aug 2021

Researchers quantify left-over COVID vaccine in used Pfizer-BioNTech vials

A new observational study, published on medRxiv* preprint server, has evaluated the unused residual Pfizer-BioNTech vaccine in vials. Bainbridge Prepares (BP), an organization consisting of community medical and non-medical volunteers, supported the research.

11 Aug 2021

Norwegian study on the benefits of COVID vaccination for residents and employees in nursing homes

It is important to understand the vaccine effectiveness (VE) to determine how much protection it offers to the general population. Unfortunately, only a few studies are available that have determined the effect of the COVID-19 vaccine among the residents of LTCFs.

11 Aug 2021

Vaccine News and Research

Latest Vaccine News and Research

CDC recommends additional dose of mRNA COVID-19 vaccine in moderately to severely immunocompromised people

Pfizer CEO to public: Just trust us on the covid booster

How replication and recombination contribute to emergence of SARS-CoV-2 variants

Advances in plant-made vaccines revive interest in plant-produced pharmaceuticals and edible drugs

Research debunks myth that COVID vaccination promotes mutations

SARS-CoV-2 variants containing L452R spike mutation more resistant to antibody-mediated neutralization

CDC's mask guidance may have increased the threat of COVID-19 among vulnerable communities

PAHO Director expresses concern about COVID-19 vaccine hesitancy in Caribbean countries

Over 70% of young people in England vaccinated with a first dose of COVID-19 vaccine

KHN’s ‘What the Health?’: The Senate acts

South Australian-developed SARS-CoV-2 vaccine shows promise to prevent COVID-19 lung infection

Reading, ’rithmetic and resisting covid: The new 3 R’s as kids head back to school

National academies’ report took pharma-friendly stance after millions in gifts from drugmakers

Getting a covid vaccine during pregnancy even more urgent as ICU beds fill up

Immunogenicity of mRNA vaccine against emerging strains of SARS-CoV-2 in immunocompromised patients

Researchers quantify left-over COVID vaccine in used Pfizer-BioNTech vials

Norwegian study on the benefits of COVID vaccination for residents and employees in nursing homes

Evaluation of mRNA vaccine responses with a surrogate SARS-CoV-2 viral neutralization assay

Breakthrough SARS-CoV-2 infections in patients with systemic rheumatic diseases

University of Ottawa announces compulsory vaccination for all students and staff visiting the campus

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in